Use of Infrared Spectroscopy in Fast Septic Arthritis Diagnosis (SYNOFRESH)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49933
- CHU Angers
-
Brest, France, 29200
- CHRU Brest
-
Clermont-Ferrand, France, 63003
- CHU clermont-ferrand
-
Nantes, France, 44000
- CHU Nantes
-
Rennes, France, 35033
- CHU de Rennes
-
Tours, France, 37044
- Chru Tours
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients over 18 year old
- patients with an acute arthritis defined by an evolution of less than 6 weeks
- patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study
- patients who received information about the protocol and have not expressed opposition to participate
Exclusion Criteria:
- patients opposing the study
- protected major (safeguard justice, trusteeship and guardianship) and persons deprived of liberty
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnosis of the cause of joint effusion
Time Frame: Up to 7 days (time to perform Spectroscopy and collect laboratory results)
|
The final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis
|
Up to 7 days (time to perform Spectroscopy and collect laboratory results)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of days of hospitalization
Time Frame: Up to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)
|
The clinician will be asked to state how a positive or a negative result of the diagnostic test under study would have affected his decision to hospitalize the patient
|
Up to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)
|
|
Total dose of antibiotics
Time Frame: Up to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)
|
The clinician will be asked to state how a positive or a negative result of the diagnostic test under study would have affected his decision to start antibiotic therapy
|
Up to 2 months (time to collect data on hospitalization duration and antibiotic therapy duration)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 35RC18_8857_SYNOFRESH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.